Strumento inattivo

Azioni Santarus, Inc.

Azioni

Prezzo di chiusura Nasdaq Altri mercati azionari
- ^USD	-

Santarus, Inc. : Relocation Plans, Patient Enrollment, Management Appointments, and Price Movements - Research Report on HCA Holdings, Opko Health, Santarus, Coronado, and Idera	31/12/13
Santarus, Inc. : Santarus Announces Availability of Amended Tender Offer Materials	30/12/13
Santarus, Inc. : Santarus Initiates Phase IIa Study with SAN-300 in Patients with Active Rheumatoid Arthritis	23/12/13
Santarus, Inc. : Ryan & Maniskas, LLP Announces Investigation of Santarus, Inc.	11/11/13
The Ryland Group, Inc. : Dow, S&P 500 end higher for fifth straight week; financials lead	08/11/13

Settore

	Variaz. 1 gen.	Capi.
CSL LIMITED	-3,93%	86,16 Mrd
SAMSUNG BIOLOGICS CO.,LTD.	+2,76%	40,17 Mrd
BIOGEN INC.	-16,99%	31,47 Mrd
UCB	+54,44%	25,24 Mrd
BIOMARIN PHARMACEUTICAL INC.	-11,96%	15,82 Mrd
BEIJING WANTAI BIOLOGICAL PHARMACY ENTERPRISE CO., LTD.	-9,12%	11,96 Mrd
INCYTE CORPORATION	-15,03%	11,89 Mrd
CHONGQING ZHIFEI BIOLOGICAL PRODUCTS CO., LTD.	-42,56%	11,61 Mrd
SWEDISH ORPHAN BIOVITRUM AB	+4,87%	8,84 Mrd